Posted by ed_uk2010 on January 30, 2011, at 13:18:54
In reply to Re: nardil went generic, posted by europerep on January 27, 2011, at 16:45:15
>Would that indicate that MAOIs, or phenelzine in particular, are actually becoming (somewhat) more likely to be prescribed again?
I believe that Gavis pharma specialise in marketing niche products. I suspect that they thought that by becoming only manufacturer of generic phenelzine tablets, they would be able to gain a large market share quite quickly with no price competition from other generics manufacturers. This will allow them to sell at a price which is high enough to make the whole thing worthwhile.
poster:ed_uk2010
thread:978029
URL: http://www.dr-bob.org/babble/20110130/msgs/978277.html